MarketWise (MKTW) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
20 Mar, 2026Executive summary
FY 2025 billings reached $271.2M, up 13.4% YoY, exceeding guidance; Q4 billings rose 42% YoY to $79M.
Cash flow from operations (CFFO) for FY 2025 was $46M, up $68M from FY 2024 and beating guidance.
Net income for FY 2025 was $64M, down from $93M in FY 2024.
Returned $1.90 per share in dividends (13% yield) and initiated/resumed a $50M share repurchase program.
Cash position increased to $70M with no debt at year-end.
Financial highlights
GAAP net revenue for FY 2025 was $328.1M, a 20% decrease from $409M in FY 2024 due to deferred revenue recognition.
Q4 2025 billings were $78.9M, up 42% YoY; CFFO for Q4 was $24.2M, up $18.2M YoY.
Paid subscribers declined to 374K at year-end 2025 from 506K in 2024, but ARPU increased to $670.
Operating expenses decreased across all major categories, supporting margin expansion.
CFFO margin for FY 2025 was approximately 17%.
Outlook and guidance
FY 2026 billings target set at $300M (+10% YoY); CFFO target of $50M (+9% YoY) with a 16% margin.
Dividend target for FY 2026 is $1.80 per Class A share, reflecting a 13% yield at current prices.
Tax distributions expected to decline by $15M in FY 2026, with cash balances projected to dip in H1 and recover in H2.
Strategic focus on subscriber growth, billings growth, and margin expansion.
Latest events from MarketWise
- Q4 2024 saw a return to billings growth, improved margins, and renewed strategic focus.MKTW
Emerging Growth Conference 7810 Jan 2026 - Shareholders to vote on director elections, equity plan amendment, and new auditor ratification.MKTW
Proxy Filing1 Dec 2025 - Vote on reverse stock split and share reduction to maintain Nasdaq listing and streamline capital structure.MKTW
Proxy Filing1 Dec 2025 - Vote to approve a 1-for-20 reverse stock split and reduce authorized shares for Nasdaq compliance.MKTW
Proxy Filing1 Dec 2025 - Key votes include director elections, incentive plan amendment, and auditor ratification.MKTW
Proxy Filing1 Dec 2025 - Q3 2025 net income was $17.9M on $81.3M revenue, with ARPU up 35.5% and a buyout proposal pending.MKTW
Q3 20256 Nov 2025 - Q2 2025 saw revenue and subscribers fall, but cash flow, billings, and capital returns strengthened.MKTW
Q2 20257 Aug 2025 - Net income rose to $22.7M in Q3 2024 despite sharp declines in revenue and subscribers.MKTW
Q3 202413 Jun 2025 - Net income surged to $21.2M in Q2 2024, while billings fell 40% amid Legacy Research wind-down.MKTW
Q2 202413 Jun 2025